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Abstract
Bear bile has been used in Traditional Chinese Medicine (TCM) for thousands of years. Modern
investigations showed that it has a wide range of pharmacological actions with little toxicological
side effect and the pure compounds have been used for curing hepatic and biliary disorders for
decades. However, extensive consumption of bear bile made bears endangered species. In the
1980's, bear farming was established in China to extract bear bile from living bears with "Free-
dripping Fistula Technique". Bear farming is extremely inhumane and many bears died of illness such
as chronic infections and liver cancer. Efforts are now given by non-governmental organizations,
mass media and Chinese government to end bear farming ultimately. At the same time, systematic
research has to be done to find an alternative for bear bile. In this review, we focused on the
literature, laboratory and clinical results related to bear bile and its substitutes or alternative in
English and Chinese databases. We examined the substitutes or alternative of bear bile from three
aspects: pure compounds derived from bear bile, biles from other animals and herbs from TCM.
We then discussed the strategy for stopping the trading of bear bile and issues of bear bile related
to potential alternative candidates, existing problems in alternative research and work to be done
in the future.
Background
Bears live in all the continents except Africa, Antarctica,
and Australia, and they are classified into eight species
including giant panda (Ailuropoda melanoleuca). The larg-
est among all is polar bear (Thalarctos maritimus), fol-
lowed by brown bear (Ursus arctos), American black bear
(Ursus americanus), Asiatic black bear (Selenarctos thibeta-
nus), spectacled bear (Tremarctos ornatus), sloth bear
(Melursus ursinus), and sun bear (Helarctos malayanus). All
of these species are endangered – five are listed in Conven-
tion on International Trade in Endangered Species of Wild
Fauna and Flora (CITES) Appendix I, whilst the remaining
three are listed in Appendix II [1].
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China was the first country utilizing bear bile and its gall
bladder in traditional medicinal products and this usage
was adopted by Korea and Japan [2,3] centuries ago.
Today the use of Traditional Chinese Medicine (TCM) was
widespread not only in Asia but also throughout Asian
communities in other areas of the world, including
Europe and America. Many of these consumers bought
bear bile products, either because they believed it was a
traditional medicine, or because the products were mar-
keted well by local TCM pharmacies.
Bear bile and bile extraction in TCM were under the cate-
gory of animal drugs. Its medicinal functions were well
documented in ancient Chinese medicinal and modern
Chinese medicine publications [4,5]. Some recent text-
books and books of TCM still recommend formulae con-
taining various animal tissues such as tiger bones,
antelope, buffalo or rhino horns, deer antlers, testicles
and penis of the dog, bear or snake bile. Some of them
have drawn attention from international [6,7]. Usually,
animal tissues were combined with medical herbs to form
Chinese Medicine preparations and in most of the cases,
the medical use of these preparations was justified in
terms of the rules of TCM. However, only a few researches
have been done to prove the claimed clinical efficacy of
TCM animal products. Still, J. (2003) [8] has published a
review paper in discussing some related ecological, ethico-
legal and health concerns about hunting, breeding and
trading with endangered species, risks of transmission of
zoonoses, quality of the products, and alternatives to the
preparations from endangered species.
Bear bile used in traditional chinese medicine
Traditional properties and actions
Bear bile (Xiongdan in Chinese) is the dried gallbladder
with bile of selenarctos thibetanus curvier or Ursus arctos L.
The dried gallbladder with bile from other species of Ursi-
dae can be also used as Bear bile. Bear bile was first
recorded in <Tang Ban Cao> (Newly Revised Materia
Medica, Tang Dynasty, 659 A.D.), the first official book
compiled and issued by the government and considered
to be the first pharmacopoeia in China. From the point of
view of TCM, bear bile was considered as a cold medicine,
bitter in flavor, cool in nature and attributive to liver, gall-
bladder and heart, so it could clear heat to relieve toxin,
stop endogenous wind to arrest convulsion and clear
away liver fire to improve eyesight [5,9,10].
Clinical indications
In traditional clinical practice, bear bile was used in fever
fighting, detoxification, inflammation, swelling and pain
reduction. It was also used in the cure of carbuncle of heat
type, pyocutaneous diseases, hemorrhoid, overabundance
of liver-fire, convulsion caused by the overabundance of
heat, epilepsy, tic, and redness of eyes due to liver heat
etc[5].
Application
For seasonal febrile disease with high fever in children
and infantile convulsion, bear bile can be dissolved in
milk or succus from Bambusae (Zhulishui in Chinese).
For heat-toxin syndrome manifested by skin carbuncle,
sore throat and hemorrhoids, bear bile can be used as oral
administration or external use. In treating conjunctivitis
and nebula, it is prepared to be a water solution as eye-
wash or used together with Borneolum (Bingpian in Chi-
nese) [5]. Besides traditional use, the modern application
of bear bile was extensive spread to many modern diseases
based on traditional indications and pharmacological
studies (also see Pharmacological study of bear bile and
Scientific research).
Usage and dosage
0.25–2.5 g is taken as a dose in pill or powder. It is mainly
single use and rarely used together with other herbs. Due
to its fishy and bitter taste that may induce vomiting, it
should be given as capsules. For external use, the fine
powder can be applied to the local area or used with water
[5].
Notes
Being extremely bitter and cold, it is easy to injure yang-qi
of the spleen and stomach and so, it is contraindicated for
deficiency and cold of the spleen and stomach [5].
Modern research of bear bile
Chemical analysis of bear bile
Over the years, extensive research has been done in estab-
lishing methods to analyze and quantify the total and
individual bile acids and their glycine and taurine conju-
gates in serum [11,12], pharmaceuticals [13,14], and bile
[15-17], including bear gall drainage [18]. These methods
mainly consisted of thin layer chromatography [13,18,19]
and high-performance liquid chromatography [11,12,14-
17,20,21].
Modern chemical research indicated that bear bile was
mainly composed of bile acids, amino acids, bile pig-
ments, fat and a few phospholipids and trace metals
[22,23]. Bile acids were regarded as the principle compo-
nents of bear bile in medical applications. It contained
ursodeoxycholic acid (UDCA), chenodeoxycholic acid
(CDCA), and cholic acid (CA). They usually occurred in
form of conjugates solely with taurine in N-acyl linkage
[22,24,25]. UDCA (3 alpha, 7 beta-dihydroxy-5 beta-cho-
lan-24-oic acid) was found to be the primary bile acid pro-
duced in the liver of bears [26,27] and the relative high
content of UDCA (1–39%) in bear (Ursidae) bile made it
different from the ones originated from pandas, related
carnivores (< 0.5%) [28] and other vertebrates [29].
It is important to note that variation of bile acid composi-
tion in bear bile was present. Espinoza EO et al. (1993)Journal of Ethnobiology and Ethnomedicine 2009, 5:2 http://www.ethnobiomed.com/content/5/1/2
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[24] reported that the bile originated from farmed bears
(bears with chronic biliary fistulae, See also Section 4.2
Extracted bear bile powder) was characterized by a decrease
in the percent composition of tauro-cholic acid (TCA) and
a dramatic increase in that of tauro-ursodeoxycholic acid
(TUDCA) and tauro-chenodeoxycholic acid (TCDCA).
However, results of later investigation [30] indicated that
the low content of TCA was common among wild and
farmed Asian bears, while the samples from Polar and
North American black bears showed a relative high con-
tent of TCA.
Pharmacological study of bear bile
Modern pharmacological research showed that bear bile
has the following pharmacological actions: (1) antimicro-
bial and anti-inflammatory effect, (2) anti-hepatotoxic
effect, (3) choleretic lithagogic effect, (4) anti-liver fibro-
sis, anti-tumor, anti-pyretic and sedative effect, (5) anti-
convulsant and analgesic effect, (6) lowering lipid and
hypotensive effect, (7) anti-tussive and anti-asthmatic
effect, (8) improving eyesight, (9) anti-stress and relaxing
effect [22,31].
As an anti-inflammatory drug in its clinical utilization, the
suppressive effect of bear bile on inflammation was also
investigated in extensive non-clinical studies. Using the
model of rat granulation and feet swelling, it was reported
that bear bile can significantly suppress inflammation in
animal models. Moreover, it was also observed that bear
bile can reduce the permeability of capillary vessel
[32,33].
Recently, an investigation has been conducted to investi-
gate the inhibitory effect of bear bile powder on rat liver
fibrosis induced by dimethylnitrosamine (DMN). The
results suggested that the bear bile powder could prevent
the formation of liver fibrosis induced by DMN. The
mechanism might relate to its inhibitory effect on the acti-
vation of Kupffer cell (KC) and hepatic stellate cell (HSC)
[34]. Another study investigated the effect of tauroursode-
oxyecholic acid (TUDCA), the characteristic compound of
bear bile, on activity of glutamic pyruvic transaminase
(GPT), and observed that TUDCA could significantly
reduce GPT activities in mice serum and the inhibitory
effect is independent to the concentration of substrate. No
toxicity of TUDCA could be observed in this study [35].
These research demonstrated bear bile's clinical function
as a hepatoprotective agent.
Clinical study of bear bile
Since bear bile has a wide range of pharmacological
actions with little toxicological side effect, it is now being
used clinically for curing hepatic and biliary disorders,
cardiovascular and cerebrovascular disorders, pulmonary
disorders, and ophthalmological disorders, while the pure
compound derived from bear bile, UDCA, is widely used
for hepatic and biliary disorders (also see 5.3 Scientific
research). Bear bile as well as its Chinese Medicine formu-
lae could also be applied to diabetes, nephritis, chin-
cough, hemorrhoids, chronic hepatitis B induced
jaundice, and falling sickness, etc. [22,31,36].
Resource for bear bile
Natural bear bile
Traditionally, bear bile (Xiong Dan in Chinese) was the
dried gall bladders of Tibetan brown bears (Ursus arctos
pruinosus) or Asiatic black bears (from North-Eastern and
Northern part of China) under the family of Ursidae. Later
on, gall bladders from American black bears, Sun bears
and Himalayan brown bear (Ursus arctos isabelinus) were
also used in TCM [33].
The bear bile could be further divided into two types,
namely, "Yun Dan" and "Dong Dan" in commercial mar-
ket of TCM. The quality of the former was considered to
be better. Gall bladders might be sold in whole pieces, in
shavings, or in powder form which was put into capsules.
Extracted bear bile powder
Long time ago, people got bear bile via hunting activities
but nowadays, people are used to getting bile from living
bears. In the 1980's, The People's Republic of China has
developed bear farms where over 7,000 brown bears and
Asiatic black bears were kept in small cages. An un-sterile
latex or stainless steel catheter was inserted through the
external fistula directly into the gall bladders of each bear
to drain the fluid daily either by gravity into a tray or by
suction with an un-sterile syringe. This extraction method
was called the "Free-dripping Fistula Technique". The
fluid was then dried and manufactured as "Bear Bile Pow-
der" (Bear bile extraction) [37]. The bears were suffering
extreme pain due to daily bile extractions. Many of them
often die from illnesses (such as cholecystitis, cholelithia-
sis, polyp formation, obstruction of the cystic duct, stric-
tures and partial herniation of the gall bladder wall, liver
cancer) and chronic infections caused by the presence of
foreign bodies and their open wounds [38,39].
Products made from farmed bear bile included powder,
capsules, ointments, tablets, tinctures, wines, supposito-
ries, eye drops and bile tea. Bear bile powder was the most
common type of product. It was usually produced and
packaged by the bear farms themselves.
Comparative studies in chemical components of natural
bear bile and bile extraction have been done in the past
years and the results showed that both of the natural bear
bile and the bile extraction contained similar chemical
components and the quality of natural bear bile was much
better [40-44].Journal of Ethnobiology and Ethnomedicine 2009, 5:2 http://www.ethnobiomed.com/content/5/1/2
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Bear bile in the world
Trading of gall bladders from wild bears has been exten-
sive over the past few decades. Tens of thousands of bears
have been killed in the wilds to obtain their gall bladders
and body parts, such as the paws (a delicacy in some East-
ern countries), hide, claws, meat, fat and bones. Moreo-
ver, gall bladder has been the prize as it has the greatest
commercial value. It was because prices of bear parts in
China have dramatically risen. In 1970 one kilo of bear
gall bladder cost around US $200, but by 1990 the price
had risen to between US $3,000 and US $5,000 per kilo
[45]. Recent market price with legal certification has risen
to between US $30,000 and US $50,000 per kilo (our
experience in legal market of Hong Kong). This has led to
an increased threat to bears in the past few decades as
price for bear gall bladder has increased making it a lucra-
tive trade for hunters and middlemen alike.
Illegal products containing bear bile were on sale in Tradi-
tional Medicine shops in USA, Canada, Japan, Taiwan,
Korea, Singapore, Australia and New Zealand according to
the new findings from investigations led by the World
Society for the Protection of Animals (WSPA) [46]. The
report showed bear products offered by these shops were
originated from China's bear farms.
With the great demand for bear bile products, fraudulent
products were found in the markets. Two surveys reported
that most of the bear bile products were indeed gall blad-
ders or bile originated from domestic pigs, goats, and
water buffalo or mixture with the true bear bile. Only
minority of the specimens was found purely from bears
[24,30].
Strategy for stopping the trading of bear bile
From killing bears to get bear bile to adopting bears to
extract bear bile, it failed to protect bears; on the contrary,
cruelly put them in more pity position.
Roles of non-governmental organizations (NGOs) and mass media
Non-governmental organizations (NGOs) and the public
could also play important roles on this issue, such as
arousing public awareness, sharing of survey information
that might assist governments, and raising the profile of
this issue during communications with national authori-
ties and international bodies. WSPA and its global net-
work of member societies were working hard in
requesting the Chinese Government to close down the
bear farms.
In July 2000, an official signing ceremony among Animals
Asia Foundation (AAF), the China Wildlife Conversation
Association in Beijing and the Sichuan Forestry Depart-
ment of China present, took place in public in Hong Kong
where the "China Bear Rescue" agreement was announced
to the worldwide press. The Agreement Summary was as
follows [47]:
(1) The short-term goal was to close down the worst farms
in Sichuan, China and to rescue 500 bears; this goal had
been reached by end of March, 2008.
(2) The medium-term goal was to expand this program
across China and continually reduce the number of bears
on farms; and
(3) Finally, the long-term goal was to end bear farming
and provide care and refuge for the remaining number of
bears.
In this agreement, effort was given in supporting the
research about the manufacture and the use of herbal and
synthetic substitutes to bear bile and, in encouraging all
consumers to refuse the use of any products containing
bear bile. The Chinese officials would continue to main-
tain her policy of prohibiting the export of bile interna-
tionally. They would also launch public education
programmes on the protection of wildlife and to preserve
and protect the natural habitat of bears.
The AAF had agreed to pay a certain level of compensation
to the farmers in an effort to ensure that none of these
bears were slaughtered anymore for their parts. At the
same time, it helped those affected bear farmers moved
into alternative areas of employment. The Sichuan gov-
ernment passed the original copies of all confiscated
licenses to AAF and a countrywide policy was set up in
China to ensure that no new bear farm license would be
issued.
However, bear farming still existed and WSPA believed
there was no humane method of bile extraction. The farm-
ing bears for bile should be stopped as soon as possible
due to the extreme animal cruelty involved and the nega-
tive effects on wild bear conservation.
To stop the illegal bear products trade and to protect wild
bear populations, collaborations between CITES (Con-
vention on International Trade in Endangered Species of
Wild Flora and Fauna), national and local governments
were needed to ensure that effective regulations and legis-
lation were founded and executed.
In addition, direct communication with Chinese govern-
ment was necessary to determine her long-term strategy
for the bear farms, and to explain the reasons why bear
farming should be ended.
If the demand for the bear bile products diminished, then
illegal trade would stop automatically. Thus, public and
consumer awareness programs should be carried out inJournal of Ethnobiology and Ethnomedicine 2009, 5:2 http://www.ethnobiomed.com/content/5/1/2
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key countries. Educational materials for the Traditional
Medicine communities, including practitioners, traders
and consumers need to create awareness of the wildlife
conservation and animal welfare issues associated with
the bear products.
Government policy
As the major production country of bear bile products, the
Chinese government implemented some measures to pro-
tect the bear. In 2001, Ministry of Health announced that
health products made of bear bile powder would not be
approved any more in order to protect the sources of wild
animals and guarantee the safety of health products. Since
then, no such product was approved by Ministry of
Health.
In 2005, regulations on the usage of bear bile in Chinese
Medicine products were stipulated by the Chinese govern-
ment. Food and Drug Administration of all provinces, and
municipality directly under the Central government
should strictly adhere to the regulations by limiting the
usage of bear bile powder in Chinese Medicine products.
Manufacturers of these products should submit their
applications to their local Food and Drug Administration
by listing out their categories, number of production and
materials used, especially if there was bear bile powder.
As a matter of fact, it became a dilemma of whether bear
bile should be used or not. The usage of bear bile was a
problem of history, culture and economy and it might
also become a political issue. On the one hand, there was
pressure from wild animal protection groups on the Main-
land and overseas. On the other hand, bear bile was an
important raw material of TCM. No alternative materials
could replace its integrative effects of pain-killing and
anti-inflammatory for the time being. By far, there were
123 Chinese medicine products made of bear bile and
183 enterprises supported by bear bile powder [48]. Fac-
ing these two challenges, if bear farming industry had to
be eliminated within China, an alternative for bear bile
should be found out and widely promoted for producing
Chinese Medicine products.
Scientific research
To look for an alternative of bear bile, a systematic
research has to be done. The definition of "alternative"
was a kind of material, which originated from animals or
plants that were not classified as endangered species. It
should also have medicinal effects similar to that of bear
bile and could totally replace it in terms of clinical use.
In fact, some research has been done on alternative for
bear bile from three aspects including: (1) animal drug
substitutes, (2) pure chemical substitutes, and (3) plant
drug substitutes. However, it would not be able to stop
using bear bile immediately even an alternative was avail-
able. It was because it needs a long time to promote this
alternative and gain acceptance from people by changing
their culture, economic system and medical practice.
Comparative study of other animal biles
The bile acid compositions of several fowls and domestic
animals, including toad, rabbit, chicken, pig and cattle,
were preliminarily studied [29]. The results indicated that
toad bile mainly composed of CA. In chicken bile, there
were both CDCA and CA. Deoxycholic acid (DCA) was
found in rabbit bile, while hyodeoxycholic acid (HDCA),
lithocholic acid (LCA) and CDCA were present in pig bile.
The composition of cattle bile was characterized by CA,
DCA and minor CDCA.
The studies on bile of rabbits and pigs have been exten-
sively carried out in comparison with those from other
animals.
It was reported that both bear and pig bile solutions were
shown to have anti-inflammatory, anti-convulsion and
analgesic effects. They could also prolong the survival
time of mice under hypoxic conditions. It was possible
that pig gall bladders could be developed as an alternative
for bear gall bladders in certain prescriptions of Chinese
medicine [49].
Comparison between pharmacologic actions of rabbit
bile and bear bile was also carried out. It was reported that
many pharmacologic actions of the rabbit bile were simi-
lar to those of bear bile. It was also demonstrated that the
effects of the rabbit bile were more obvious than those of
bear bile in positive inotropic action, sedation, anti-tus-
sive action, and anti-histaminic action, etc. [50].
These two kinds of gall bladders were generally consid-
ered to be able to substitute bear bile based on their chem-
ical and pharmacological effects.
Pure chemical substitutes
Among the chemical components in bear bile, bile acids
were the main effective components, which consisted of
UDCA and CDCA. These two bile acids were a pair of iso-
mer and the former made bear bile different from other
animal biles. In other words, bears were the only mam-
mals to produce significant amounts of UDCA (apart
from giant pandas, which do not produce UDCA). It was
also the UDCA which gave bear bile beneficial medicinal
effects.
Although UDCA was also found in other animal species
and could be extracted from pig bile and cow bile, the
quantity was too little for large scale production. Japanese
scientists succeeded in chemically synthesizing UDCA in
1955 [51]. Today, large quantities of UDCA were made
synthetically and widely used in Western medicine to dis-Journal of Ethnobiology and Ethnomedicine 2009, 5:2 http://www.ethnobiomed.com/content/5/1/2
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solve gallstones. It was estimated that 100,000 kg of this
synthetic UDCA was being consumed each year in China,
Japan and South Korea, and that the world consumption
may double this figure.
Oral administration of either UDCA or CDCA could
desaturate bile and contribute to the dissolution of cho-
lesterol gallstones. However, the former was found to be
better tolerated with fewer adverse side effects in compar-
ison with the latter. In addition, recent evidence suggested
that UDCA might be an effective drug in various chronic
liver diseases, especially cholestatic disorders such as pri-
mary biliary cirrhosis [52].
A review paper was found to explain the rationale sup-
porting the use of UDCA for the treatment of patients with
cholesterol gallstones and chronic liver diseases and to
describe the results obtained in clinical trials. The conclu-
sion was that UDCA was a safe and effective drug for the
treatment of patients with cholesterol gallstones [53].
The substitutes from Chinese herbs
In TCM, bear bile was classified under the category of
clearing heat and detoxification drugs. In respect to the
same medicinal functions, some Chinese herbs were also
found to have the efficacies of clearing heat and detoxifi-
cation, purifying liver and improving eyesight. It was sug-
gested that one or more of these herbal medicines could
be used as an alternative for bear bile [10,54,55]. A recent
study on herbal alternatives to bear bile reported Scutel-
laria baicalensis Georgi, Huangqin in Chinese, and its
active components, chrysin and wogonin, exhibited
inhibitory effect on IL-6 promoter activity, indicating its
potential as an anti-inflammation agents and an alterna-
tive to bear bile, traditional anti-inflammatory agent [56],
but it is hard to say that Huangqin is a good candidate for
substitute of bear bile because bear bile has multiple phar-
macological action.
According to TCM herbal classification and the survey
conducted for Chinese Medicine Practitioners by World
Society for the Protection of Animals in Australia, Canada,
USA, and UK, etc., Chinese herbs with the efficacies of
clearing heat and detoxification included: Lobeliae chinen-
sis, Herba cum Radice; Oldenlandiae Diffusae, Herba; Patrin-
iae seu thiaspi, Herba cum Radice;  Pulsatillae Chinensis,
Radix; Dictamni dasycarpi, Cortex Radicis; Andrographis pan-
iculatae, Herba); Sedi sarmento, Herba; Isatidis, Folium; Sar-
gentodoxae, Caulis;  Lonicerae Japonicae, Flos;  Forsythiae
suspensae, Fructus; Lasiospherae seu calvatiae, Fructificatio;
Portulacae oleraceae, Herba; Taraxaci mongolici, Herba cum
Radice; Indigonis, Pulvis; Sophorae subprostratae, Radix; Bela-
mcandae chinensis, Rhizoma;  Houttuyniae cordatae, Herba
cum Radice; Paridis, Rhizoma, and Violae yedoensitis, Herba
cum Radice.
Chinese medicines under the category of plant with the
efficacy of clearing heat included: Gentianae scabrae, Radix;
Aloes, Herba; Paridis, Rhizoma; and Violae yedoensitis, Herba
cum Radice.
Chinese medicines under the category of plant with the
efficacy of purifying liver and improving eyesight
included: Plantaginis, Semen; Lycii chinensis, Fructus; Erio-
caulon buergerianum, Spica; Cassiae torae, Semen; Chrysan-
themi morifolii, Flos;  Viticis, Fructus;  Buddleiae officinalis,
Flos Immaturus; Equiseti hiemalis, Herba; Ligustri lucidi, Fruc-
tus; Citri reticulatae viride, Pericarpium; Celosiae argenteae,
Semen; Mori albi, Folium, and Prunellae vulgaris, Spica.
Other Chinese medicines under the category of plant with
the efficacy of protecting liver and improving eyesight
included: Astragali complanati, Semen; Lycii chinensis, Fruc-
tus; Ligustri lucidi, Fructus, and Dendrobii, Herba.
Although bear bile had the efficacy of clearing heat and
detoxification, purifying liver, improving eyesight, and
could be used to treat eclampsia, epilepsy, tic, hot liver,
red eyes and swollen problem, it did not have the func-
tions of protecting liver and could not be used to treat vis-
ual disturbance caused by weak liver and kidney
according to TCM theory. As a result, scientists in pharma-
cology of Chinese medicine and Chinese Materia Medica
were required to work together with TCM practitioners
closely in order to find an alternative for bear bile. In
other words, experts were required to carry out detailed
research work and to propose scientific research method-
ology. Afterwards, stringent implementation should be
ensured for proving the similar efficacies and mutual sub-
stitutability of the alternative.
Coptis as a herbal alternative to bear bile
Among the possible alternatives for bear bile, Coptis
("Huanglian" in Chinese) was a possible choice since
both of these materials were under the category of clearing
heat. Apart from that, both bear bile and Coptis  could
detoxify, purify liver, improve eyesight, as well as treating
eclampsia, epilepsy, tic caused by fire, carbuncle of heat
type, pyocutaneous diseases. At present, prescriptions
with Coptis (such as Huang Lian Jie Du Tang, Qing Ying
Tang, and An Gong Niu Huang Wan) were widely used to
treat symptoms such as coma, eclampsia, epilepsy, tic and
we have also used it to treat liver diseases (Major active
compound, UDCA derived from bear bile is mainly used
for liver diseases) and cancer in TCM clinical practice[57].
Now, we are doing comparative research between bear
bile and Coptis  in chemical analysis, pharmacological
study and clinical efficacy to clarify what we concern.
Natural resources of Copis
According to China Pharmacopeia (Edition 2005), three
species of plants are regarded as the genuine resource ofJournal of Ethnobiology and Ethnomedicine 2009, 5:2 http://www.ethnobiomed.com/content/5/1/2
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Coptis for medical utilization, Coptis chinensis Franch,
Coptis deltoidea C.Y. Cheng et Hsiao and Coptis teeta
wall. All these three species can be found in Mainland
China. It was reported that Coptis teeta wall mainly grows
in Yunnan Province of China, therefore it is named as
Yunhuanglian in Chinese. Meanwhile, Coptis chinensis
Franch (Chuanhuanglian or Weilian in Chinese) and
Coptis deltoidea C.Y. Cheng et Hsiao (Yalian) grow in
Sichuan Province. However, some other species are also
used as resources of Coptis, such as Coptis omeiensis
(Chen) C.Y. Cheng and Coptis chinensis Franch.var.
brevisepala Wang et Hsiao [58].
Brief history of the traditional use of Coptis
Coptis (Huanglian) was firstly recorded in, <Shen Nong
Ben Cao Jing>, a medical classic written in Han Dynasty,
and was selected as a herbal drug for clearing heat and
scavenging toxics. Moreover, in the ancient pharmacopeia
<Ben Cao Gang Mu> in Ming Dynasty, Coptis and its for-
mulations were used as therapeutic agents for eye diseases
and diarrhea. A recent study summarized that Coptis in
single dose form was most commonly used for the treat-
ment of eye diseases in some ancient medical books
(comprising 14.58% of the total records) [59]. Consider-
ing that optical system has close relationship with liver
according to Chinese Medicine theories, these records
indicates that Coptis may function to benefit liver organ,
which is also regarded as parts of the pharmacological
effect of bear bile in its traditional utilization. These links
provide some evidences even inspirations for the use of
Coptis as an alternative to bear bile. In terms of clinical
applications, it was surprising to find the unexpected sim-
ilarities between Coptis and bear bile, such as detoxify,
purify liver, improve eyesight, as well as treating eclamp-
sia, epilepsy, tic caused by fire, carbuncle of heat type,
pyocutaneous diseases, sore throat and hemorrhoids.
Chemical composition and pharmacological actions of Coptis
The chemical composition of Coptis is complicated and
dependent on species of samples. However, some com-
mon components amongst different species have been
isolated and identified, including berberine, coptisine,
palmatine, jatrorrhizine and magnoflorine[60]. In China
Pharmacopeia (Edition 2005), berberine is used as a crite-
rion for quality control of the Coptis. Thin layer chroma-
tography and high performance chromatography analysis
on berberine provide qualitative and quantitative evalua-
tion to the herbs. Nonetheless, single criterion has its lim-
itation in quality control system. Studies in our group
have established, using HPLC-MS/MS, the chemical pro-
file of Coptis and have made comparison on the chemical
composition amongst species (data not shown). Differ-
ences can be easily observed from chromatograms so this
provides a direct but comprehensive approach for the
quality control of Coptis.
Extensive studies exhibited that Coptis has many pharma-
cological actions with strong clinical implications, includ-
ing antibacterial, antiviral, antiinflammatory,
antineoplastic, antihypertensive, antioxidative, antihyper-
glycemic and cholesterol-lowering effects [61-68]. Bioa-
vailability of pure compound berberine derived from
coptis is variety, traditionally it has been thought that ber-
berine is poorly absorbed, but it has been reported that
absorption in the mouse and human is good [69-71]. Pre-
vious studies in our group displayed that Coptis and its
major component berberine showed promising potential
as drug candidates for the treatment of liver injury [[72]
and unpublished data]. It was also found from our in vitro
study that Coptis and berberine can suppress cancer cell
lines [[73] and unpublished data]. These positive data add
new pharmacological activities for coptis and berberine
and indicate the potential of coptis and berberine as an
alternative to bear bile. Now comparative study on coptis
and bear bile is our ongoing PhD program training
project.
Conclusion
To summarize, it was believed that the usage of bear bile
is a problem of history, culture and economy and it may
also become a political issue. Before stopping use of bear
bile, it needs combined efforts from various routes of the
society. As we reviewed in this paper, research on alterna-
tive for bear bile has been conducted in the past decade
including comparative studies of various animal biles, the
major effective components of bear bile, and substitutes
of bear bile by artificial materials and herbal medicines. In
this review, it showed that animal biles, such as those
from pigs and rabbits, the synthetic compound of UDCA,
and herbs, such as Coptis, were possible substitutes for
bear bile. However, plant substitutes were only suggested
in literature without solid evidence to support, while
some animal substitutes were superficially studied. Thus,
it is necessary for us to design systematic, serious and
comparative research to get convincing data. It is impor-
tant to note that animal substitutes will be found contra-
dictory to the tenets of World Animal Protection sooner or
later. The final choice will be using plant materials to sub-
stitute bear bile. Our previous study showed Coptis was a
promising drug due to its similarity to bioactivity charac-
teristics of bear bile, therefore comparative study for both
Coptis and bear bile will be carried out. More persuasive
research has to be done to explore their integrative func-
tions and prove their similarities to bear bile in terms of
medicinal use.
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